Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review
Lucy Haggstrom, Janette Vardy, Emma‐Kate Carson, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 920-920
Open Access | Times Cited: 18

Showing 18 citing articles:

Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 42
Effects of aerobic exercise on neurocognitive function in postmenopausal women receiving endocrine therapy for breast cancer: The Exercise Program in Cancer and Cognition randomized controlled trial
Catherine M. Bender, Susan M. Sereika, Amanda Gentry, et al.
Psycho-Oncology (2024) Vol. 33, Iss. 2
Closed Access | Times Cited: 9
Cognitive impairment following breast cancer treatments: an umbrella review
Giulia Oliva, Andreina Giustiniani, Laura Danesin, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e848-e863
Open Access | Times Cited: 7
Unveiling Cognitive Impairment in Older Adults with Cancer on Systemic Anticancer Therapy: A Comprehensive Review
Rémi Fernandez, Gemma Fargas Baella, V. Slavova-Boneva, et al.
Drugs & Aging (2025)
Closed Access
Long-term health-related quality of life among adolescent and young adult breast cancer survivors
Noëlle J. M. C. Vrancken Peeters, Roos Kerklaan, Carla Vlooswijk, et al.
Quality of Life Research (2025)
Open Access
Administrator, Provider, and Staff Perspectives on Implementing Acupuncture in Medically Underserved Breast Cancer Survivors
Hongjin Li, Ardith Z. Doorenbos, Hannah Choi, et al.
Cancer Nursing (2025)
Closed Access
Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer
Philippe R. Lee Meeuw Kjoe, Jacobien M. Kieffer, Brent J. Small, et al.
JNCI Cancer Spectrum (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 7
Hormonal basis of brain fog in cancer treatment
Yuan Pan, Jian Hu
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 5
Open Access | Times Cited: 2
Efficacy of Tango Argentino for Cancer-Associated Fatigue and Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial
Friedemann Schad, Thomas Rieser, Sarah Becker, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2920-2920
Open Access | Times Cited: 6
Design and methods of the mobile assessment of cognition, environment, and sleep (MACES) feasibility study in newly diagnosed breast cancer patients
Rebecca Derbes, Jonathan G. Hakun, Daniel Elbich, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Alzheimer Disease and Related Dementia Following Hormone-Modulating Therapy in Patients With Breast Cancer
Chao Cai, Kaowao Strickland, Sophia Knudsen, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2422493-e2422493
Open Access | Times Cited: 1
Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study
Javier García‐Sánchez, Mayra Alejandra Mafla-España, María Dolores Torregrosa, et al.
The Breast (2022) Vol. 66, pp. 310-316
Open Access | Times Cited: 7
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization’s database
Rachel Prevost, Basile Chrétien, Elise-Marie Minoc, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
A novel oncogenic enhancer of estrogen receptor-positive breast cancer
Chun‐Jie Bao, Jia‐Lun Duan, Ying Xie, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 836-851
Open Access | Times Cited: 5
Cognitive function among women with breast cancer receiving endocrine therapy: what are the impacts?
Joanna E. Fardell, Adam K. Walker, Raymond J. Chan, et al.
JNCI Cancer Spectrum (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 2
Relationship of physical activity and cognitive functioning among breast cancer survivors: a cross-sectional analysis
Sheri J. Hartman, Rong Zablocki, Rowena M. Tam, et al.
Frontiers in Cognition (2024) Vol. 3
Open Access
Computerized cognitive training improves cognitive function in primary breast cancer survivors
K Kleinknecht, Mira Bierend, Lisa-Maria Keim, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access
Therapeutic potential of RUNX1 and RUNX2 in bone metastasis of breast cancer
Fei Zhang, William C. Cho
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 6, pp. 413-417
Open Access | Times Cited: 1
Facing points of view: Representations on adjuvant endocrine therapy of premenopausal patients after breast cancer and their healthcare providers in France. The FOR-AD study
Nicolas Roche, Jean-Bernard Le Provost, Maria-Alice Borinelli-Franzoi, et al.
European Journal of Oncology Nursing (2022) Vol. 62, pp. 102259-102259
Open Access | Times Cited: 1
Page 1

Scroll to top